Andere talen Implantica AG

Aandelen

IMP A SDB

SE0014855029

Vertraagde tijd Nasdaq Stockholm Andere beurzen 11:40:24 19-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
28,95 ^SEK	+1,05%		-2,53%	+21,13%

27/03	Implantica dient eerste module in van de US FDA Premarket Approval Application voor GERD medisch hulpmiddel	MT
27/03	Implantica dient PMA-aanvraag (Premarket Approval) in bij de Amerikaanse FDA voor RefluxStop® (eerste module)	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Implantica Submits Initial Module of US FDA Premarket Approval Application for GERD Medical Device	27/03
Implantica Submits U.S. FDA Premarket Approval Application for RefluxStop® (first module)	27/03
Implantica Completes Human Factors Validation Study for RefluxStop as Part of the US FDA Premarket Approval Process	26/03
Implantica to Deploy GERD Treatment in Spain	19/03
Implantica AG (publ.) Wins Another RefluxStop Public Tender in Europe with Hospital Universitario De Getafe	19/03
Implantica AG (OM:IMP A SDB) acquired IRCCS Saverio De Bellis.	05/03
Implantica AG Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	16/02
Implantica Announces Completion of its First RefluxStop Procedures at Artemed Klinikum München Süd in Munich, Germany	15/02
Implantica Announces First Refluxstop Public Tender Win, Paving the Way for Permanent Reimbursement in Italy	13/02
Implantica Ag Announces the First RefluxStop Procedures Completed At MIC Hospital in Berlin	06/02
Implantica AG (publ.) Adds Another RefluxStop Center in Spain	18/12
Implantica AG Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	22/11
Implantica AG (publ.)'s RefluxStop Offers for the First Time in the NHS in UK	21/11
Implantica Wins EU Medical Device Certifications	07-09-23
Implantica AG Receives MDR Certification for RefluxStop?	07-09-23
Implantica AG Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	24-08-23
Implantica AG Further Expands Its Commercial Footprint in Italy	29-06-23
Implantica AG Announces RefluxStop Results Were Presented At the DDW Conference in Chicago	16-05-23
Tranche Update on Implantica AG (OM:IMP A SDB)'s Equity Buyback Plan announced on April 6, 2023.	12-05-23
Implantica AG Reports Earnings Results for the First Quarter Ended March 31, 2023	12-05-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Implantica AG

Aandelen

IMP A SDB

SE0014855029

Andere talen

Filters